A patient who recently started aripiprazole (Abilify) is experiencing flu‑like symptoms; what should be done?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Flu-Like Symptoms on Abilify: Immediate Assessment and Management

Stop aripiprazole immediately and evaluate for neuroleptic malignant syndrome (NMS), which presents with fever, muscle rigidity, altered mental status, and autonomic instability—a potentially fatal complication that requires emergency intervention.

Critical First Step: Rule Out Life-Threatening Complications

While the provided evidence focuses primarily on influenza management rather than aripiprazole-specific adverse effects, the development of flu-like symptoms (fever, myalgias, malaise) in a patient recently started on an antipsychotic demands urgent exclusion of NMS. The research evidence confirms aripiprazole can cause serious adverse effects including hypersensitivity pneumonitis 1 and cardiovascular complications 2, though it is generally well-tolerated with lower rates of adverse events compared to other antipsychotics 3, 4.

Assess for NMS Features:

  • Fever (often >38.5°C)
  • Muscle rigidity (lead-pipe rigidity)
  • Altered mental status (confusion, disorientation, drowsiness) 5
  • Autonomic instability (tachycardia, labile blood pressure, diaphoresis)
  • Elevated creatine kinase (obtain stat labs)

If any combination of these features is present, this is a medical emergency requiring immediate hospitalization.

If NMS is Ruled Out: Consider Alternative Diagnoses

Actual Influenza or Viral Illness

The patient may have coincidentally developed true influenza or another viral infection. Assess for:

  • Sudden onset of high fever, chills, cough, headache, sore throat, and fatigue 5
  • Timing: Symptoms appearing 4-5 days after influenza onset suggest possible bacterial superinfection rather than simple viral illness 6
  • Red flags requiring immediate re-evaluation: shortness of breath at rest, painful breathing, hemoptysis, disorientation, or fever persisting 4-5 days 5, 7

Management if true influenza:

  • Symptomatic treatment with ibuprofen (400 mg initially, then 200-400 mg every 4-6 hours, max 1200 mg/day) for fever, myalgias, and headache 8
  • Rest, adequate hydration, avoid smoking 5, 8
  • Oseltamivir 75 mg twice daily for 5 days only if presenting within 48 hours of symptom onset 7
  • Do NOT use aspirin if patient is under 16 years old (Reye's syndrome risk) 8, 7

Aripiprazole-Induced Hypersensitivity Reaction

The research literature documents that aripiprazole can cause hypersensitivity pneumonitis presenting with progressive dyspnea and respiratory symptoms 1. If the patient has:

  • Respiratory symptoms (shortness of breath, cough)
  • Fever without clear infectious source
  • Temporal relationship to aripiprazole initiation

Action required:

  • Discontinue aripiprazole immediately 1
  • Consider chest imaging if respiratory symptoms are present 1
  • Consult with the prescribing psychiatrist for alternative antipsychotic options

Common Pitfall to Avoid

Do not simply treat symptomatically and continue aripiprazole without first excluding serious drug-related complications. While aripiprazole has a favorable tolerability profile 3, 4, serious adverse effects including hypersensitivity pneumonitis 1 and cardiovascular events 2 have been documented. The temporal relationship between drug initiation and symptom onset is critical.

Monitoring After Aripiprazole Discontinuation

If aripiprazole is discontinued due to suspected adverse effects:

  • Symptoms should improve within days to weeks of discontinuation 1
  • Monitor for psychiatric symptom recurrence and arrange urgent psychiatric follow-up for alternative medication
  • Document the adverse reaction clearly in the medical record

If symptoms persist beyond 48 hours after aripiprazole discontinuation or worsen at any point, the patient requires urgent medical re-evaluation 5.

References

Research

Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors.

Experimental and clinical psychopharmacology, 2018

Research

Aripiprazole: pharmacology, efficacy, safety and tolerability.

Expert review of neurotherapeutics, 2005

Research

Aripiprazole: profile on efficacy and safety.

Expert opinion on pharmacotherapy, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Secondary Bacterial Pneumonia in Influenza

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Influenza-Like Illness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ibuprofen for Influenza Symptom Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.